BioNexus Gene Lab Corp. (BGLC) Stock

Basic Materials · Specialty Chemicals · Member of Other US Stocks

BioNexus Gene Lab Corp. (BGLC) closed at USD 1.26 on 2026-10-14, a change of -75.7 % over the past year, with a market capitalization of USD 3.58M.

BioNexus Gene Lab Corp. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

BioNexus Gene Lab Corp. key figures

Previous close

USD 1.26 (2026-10-14)

1-year change

-75.7 %

Market cap

USD 3.58M

Enterprise value

USD 383,397

P/E ratio (trailing)

-0.97

P/E ratio (forward)

n/a

EPS (trailing)

-1.26

EPS (forward)

n/a

PEG ratio

n/a

Price to book

0.38

Revenue growth

-96.6 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

1.98

Employees

19

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for BioNexus Gene Lab Corp. and compare it with other stocks.